The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I

BackgroundFDG-PET/CT is part of the standard diagnostic management of a patients with a large variety of common and less common malignant tumors, based on the increased glucose metabolism within tumors.Case presentationA hybrid fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) was performed in a neurofibromatosis patient to rule out relapse of malignant peripheral nerve sheet tumor. The scan revealed non-malignant neurofibromas, a testis seminoma and hypermetabolic syphilitic granulomata.ConclusionThis case stresses the need to rule out infectious diseases when atypical hypermetabolic lesions are present.

[1]  K. Sandrasegaran,et al.  Abdominal Manifestations of Neurofibromatosis , 2008, Journal of computer assisted tomography.

[2]  D. Vriens,et al.  The role of 18F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  O. Sabri,et al.  FDG PET for detection and therapy control of metastatic germ cell tumor. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  W. Oyen,et al.  Aortitis Diagnosed by F–18–Fluorodeoxyglucose Positron Emission Tomography in a Patient with Syphilis and HIV Coinfection , 2005, Infection.

[5]  C. Bokemeyer,et al.  2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. O'Doherty,et al.  [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Fosså,et al.  European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. , 2008, European urology.

[8]  E. Pasmant,et al.  Neurofibromatosis type 1: from genotype to phenotype , 2012, Journal of Medical Genetics.

[9]  J. de Kraker,et al.  Testicular tumor concomitant with von Recklinghausen's disease. , 1988, Medical and pediatric oncology.